TrialBMC nephrology2019

Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial.

Shafiq Ur Rehman Cheema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.